Starting in January 2025, Ozempic gained FDA approval for reducing kidney disease risks in adults with type 2 diabetes who also have chronic kidney disease
February 3, 2025: More Than 100 New Lawsuits Join Litigation Against Ozempic and Other GLP-1 Drugs As of February 3, 1,443 people have joined the multidistrict litigation (MDL) against Ozempics maker (Novo Nordisk) and other GLP-1 manufacturers
For current shipping status by state, check the real-time map on our homepage
Both semaglutide and tirzepatide are incredibly effective, but your individual health history, insurance coverage, and other personal factors matter when it comes to choosing one or the other
If you think you may have injected your dose into a muscle, dont worrythis can happen, and its usually not a major concern